Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vanillin and Wheat Germ Oil for Mild-to-Moderate COVID-19
NCT05157139Phase 3Unknown
- Sponsor
- Alexandria University
- Start
- Nov 2021
- Primary completion
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of vanillin in coronavirus disease 2019 (COVID-19) (3 arms), sponsored by Alexandria University. Primary endpoints: Mean change in the disease severity (clinical assessment), Rate of disease remission and 2 more. Status: unknown.
02
Drugs
vanillin
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05157139.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05157139.